CoChat

Liver cancer in 2021: Global Burden of Disease study

Tan, En Ying, Danpanichkul, Pojsakorn, Yong, Jie Ning, Yu, Zhenning, Tan, Darren Jun Hao, Lim, Wen Hui, Koh, Benjamin, Lim, Ryan Yan Zhe, Tham, Ethan Kai Jun, Mitra, Kartik, Morishita, Asahiro, Hsu, Yao-Chun, Yang, Ju Dong, Takahashi, Hirokazu, Zheng, Ming-Hua, Nakajima, Atsushi, Ng, Cheng Han, Wijarnpreecha, Karn, Muthiah, Mark D., Singal, Amit G., Huang, Daniel Q. · 2025 · Journal of Hepatology
Cited by 232

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND & AIMS The epidemiology of adult primary liver cancer continues to evolve, related to the increasing prevalence of metabolic disease, rising alcohol consumption, advancements in vaccination for hepatitis B (HBV), and antiviral therapy for hepatitis C (HCV). Disparities in care and the burden of liver cancer between populations persist. We assess trends in the burden of liver cancer and contributions by various etiologies across 204 countries and territories from 2010 to 2021. METHODS Utilizing the methodological framework of the Global Burden of Disease Study 2021, we analyzed global and regional temporal trends in incidence and mortality, and the contributions of various etiologies of liver disease. RESULTS In 2021, there were an estimated 529202 incident cases and 483875 deaths related to liver cancer. From 2010 to 2021, global liver cancer incident cases and deaths increased by 26% and 25%, respectively. Global age-standardized incidence rates (ASIRs) and death rates (ASDRs) for liver cancer declined but rose in the Americas and Southeast Asia. HBV remained the dominant cause of global incident liver cancer cases and deaths. Metabolic dysfunction-associated steatotic liver disease (MASLD) was the only etiology of liver cancer with rising ASIRs and ASDRs. By contrast, ASIRs and ASDRs remained stable for alcohol-related liver cancer, and declined for HBV- and HCV-related liver cancer. CONCLUSIONS While age-adjusted incidence and deaths from liver cancer have started to decline, the absolute number of incident cases and deaths continues to increase. Population growth and aging contribute to the observed disconnect in the temporal trends of absolute cases and rates. Disparities remain, and MASLD-related liver cancer continues to surge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2024.10.031

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 232

Metadata

Authors
Tan, E. Y., Danpanichkul, P., Yong, J. N., Yu, Z., Tan, D. J. H., Lim, W. H., Koh, B., Lim, R. Y. Z., Tham, E. K. J., Mitra, K., Morishita, A., Hsu, Y.-C., Yang, J. D., Takahashi, H., Zheng, M.-H., Nakajima, A., Ng, C. H., Wijarnpreecha, K., Muthiah, M. D., Singal, A. G., & Huang, D. Q.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2025-05
Volume
82
Issue
5
Pages
851-860
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4403910553
Cited by
232
References
12
FWCI
51.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver cancer in 2021: Global Burden of Disease study. https://app.cochat.ai/papers/10.1016/j.jhep.2024.10.031
The paper
Tan, E. Y., Danpanichkul, P., Yong, J. N., Yu, Z., Tan, D. J. H., Lim, W. H., Koh, B., Lim, R. Y. Z., Tham, E. K. J., Mitra, K., Morishita, A., Hsu, Y.-C., Yang, J. D., Takahashi, H., Zheng, M.-H., Nakajima, A., Ng, C. H., Wijarnpreecha, K., Muthiah, M. D., . . . Huang, D. Q. (2025). Liver cancer in 2021: Global Burden of Disease study. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2024.10.031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.